Catalyst Wire Dossier Catalyst Wire Dossier
EMA withdrawal · 2007-11-16

EMA Application withdrawn: Gastromotal (1-13C-caprylic acid) — INFAI, Institut für biomedizinische Analytik NMR-Imaging GmbH

View source ↗

Summary

The EMA reports that the application for Gastromotal (1-13C-caprylic acid) for gastric emptying breath tests was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gastromotal

Snippet

Status: Application withdrawn. Therapeutic area: Gastric Emptying;Breath Tests. MAH: INFAI, Institut für biomedizinische Analytik NMR-Imaging GmbH. Decision date: 31/12/2009